Zoetis Inc (ZTS)
190.03
-0.96
(-0.50%)
USD |
NYSE |
Oct 04, 16:00
189.95
-0.08
(-0.04%)
After-Hours: 20:00
Zoetis Shareholders Equity (Annual): 4.997B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.997B |
| December 31, 2022 | 4.405B |
| December 31, 2021 | 4.543B |
| December 31, 2020 | 3.769B |
| December 31, 2019 | 2.708B |
| December 31, 2018 | 2.185B |
| December 31, 2017 | 1.77B |
| Date | Value |
|---|---|
| December 31, 2016 | 1.487B |
| December 31, 2015 | 1.068B |
| December 31, 2014 | 1.311B |
| December 31, 2013 | 940.00M |
| December 31, 2012 | 4.026B |
| December 31, 2011 | 3.72B |
| December 31, 2010 | 3.344B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
2.708B
Minimum
2019
4.997B
Maximum
2023
4.084B
Average
4.405B
Median
2022
Shareholders Equity (Annual) Benchmarks
| Pfizer Inc | 89.01B |
| Alnylam Pharmaceuticals Inc | -220.64M |
| Biomarin Pharmaceutical Inc | 4.952B |
| Corcept Therapeutics Inc | 506.70M |
| Ionis Pharmaceuticals Inc | 386.69M |